| Angelman syndrome (AS) |
miR-708°Maranga et al., 2020 MECP2*/°Williams et al., 2010; Mastrototaro and Sessa, 2018; Maranga et al., 2020 SETDB1* Zhu et al., 2020
|
| Anxiety disorder |
DNMT1°Hutnick et al., 2009; Noguchi et al., 2016
|
| ATR-X syndrome |
H3K9me3* Mastrototaro and Sessa, 2018 MECP2* Bérubé et al., 2005; Nan et al., 2007
|
| Autism spectrum disorder (ASD) |
SETD2* Mastrototaro and Sessa, 2018 ANKRD11, HDAC3°Gallagher et al., 2015; Ockeloen et al., 2015; Mastrototaro and Sessa, 2018; Deurloo et al., 2019; Little and Dwyer, 2019 BAF complexes* Mastrototaro and Sessa, 2018
ST7OT1-3, ST7OT1-4*
Vincent et al., 2002 SETDB1* Cukier et al., 2012; Zhu et al., 2020 MECP2, MDB5/6* Cukier et al., 2012
|
| Down syndrome (DS) |
MECP2 Patkee et al., 2020
miR155, miR802, miR125b*
Siew et al., 2013 NRON°Willingham et al., 2005; Arron et al., 2006
|
| Epilepsy (chronic) |
DNMT1/3A* Henshall and Kobow, 2015; Dixit et al., 2018
miR-17∼˜92 cluster, miR-21, miR-155, miR-4521, miR-323a-5p, let-7f, miR-31, miR-34a*
Dixit et al., 2018
|
| Fragile-X syndrome |
miR-19b, miR-92b, miR-125b, miR-132, miR-302b, miR-323-3p, miR-363, miR-367*
Siew et al., 2013
|
| ICF syndrome |
DNMT3B*/°Miniou et al., 1997; Kondo et al., 2000; Jin et al., 2008
|
| Kabuki syndrome |
KMT2D*/°Gabriele et al., 2018 KDM6A* Gabriele et al., 2018
|
| Kleefstra syndrome (KS) |
EHMT1, EHMT2* Mastrototaro and Sessa, 2018 EZH2* Mastrototaro and Sessa, 2018 MML3, NR1I3, SMARCB1, MBD5* Mastrototaro and Sessa, 2018
|
| Luscan-Lumish syndrome |
SETD2*/°Lumish et al., 2015; Gabriele et al., 2018; van Rij et al., 2018; Rabin et al., 2020
|
| Major depression disorder |
SETDB1°Zhu et al., 2020
|
| Prader-Willi syndrome (PW) |
SETDB1°Zhu et al., 2020
|
| Rett syndrome (RTT) |
MECP2*/°Mastrototaro and Sessa, 2018; Pejhan et al., 2020
miR30a, miR381, miR495°Wu et al., 2010
miR132*
Pejhan et al., 2020
AK081227 and AK087060°Petazzi et al., 2013
|
| Schizophrenia (SZ) |
DNMT1/3a°Kirkbride et al., 2012; Matrisciano et al., 2013 SETDB1*/°Zhu et al., 2020
|
| Tatton-Brown-Raham syndrome (TBRS) |
DNMT3A* Lane et al., 2020; Yokoi et al., 2020
|
| Van-Maldergem syndrome (VMS) |
TET1°Cappello et al., 2013
|
| Weaver syndrome (WS) |
EZH2* Al-Salem et al., 2013; Lane et al., 2020 NSD1* Al-Salem et al., 2013; Paradowska-Stolarz, 2014; Donovan and Basson, 2017
|
| Williams-Beuren syndrome (WBS) |
SETD2* Mastrototaro and Sessa, 2018 LSD1/KDM1A, HDAC2* Mastrototaro and Sessa, 2018; Deurloo et al., 2019
|
| Wolf-Hirschhorn syndrome (WHS) |
NSD2°Riazi et al., 2005; Nimura et al., 2009
|
